Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.

Cheung, N K; Walter, E I; Smith-Mensah, W H; Ratnoff, W D; Tykocinski, M L; Medof, M E

Cheung, N K; Walter, E I; Smith-Mensah, W H; Ratnoff, W D; Tykocinski, M L; Medof, M E.

Affiliation

Cheung NK; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York 10021.

J Clin Invest ; 81(4): 1122-8, 1988 Apr.

Article in En | MEDLINE | ID: mdl-2450893

Subject(s)

Complement System Proteins/physiology; Membrane Proteins/physiology; Neoplasms, Experimental/immunology; Antibodies, Monoclonal; CD55 Antigens; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Immunologic Techniques; Tumor Cells, Cultured

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complement System Proteins / Membrane Proteins / Neoplasms, Experimental Limits: Humans Language: En Journal: J Clin Invest Year: 1988 Type: Article

Fulltext

XML

PubMed Links

Search on Google